Evidence map›Paper›PMID 39290874›Full record

ArticleNeuro-oncology advances

Segmentation of pre- and posttreatment diffuse glioma tissue subregions including resection cavities.

Saif Baig, Igor Vidic, George M Mastorakos, Robert X Smith, Nathan White, Suzie Bash, Anders M Dale, Carrie R McDonald, Thomas Beaumont, Tyler M Seibert and 4 more

Abstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Saif BaigDepartment of Radiology, Nassau University Medical Center, East Meadow, New York, USA.ORCID https://orcid.org/0000-0002-8172-0151
Igor VidicCortechs.ai, San Diego, California, USA.ORCID https://orcid.org/0000-0001-6610-1187
George M MastorakosCortechs.ai, San Diego, California, USA.
Robert X SmithCortechs.ai, San Diego, California, USA.
Nathan WhiteCortechs.ai, San Diego, California, USA.
Suzie BashRadnet, San Fernando Valley, California, USA.ORCID https://orcid.org/0000-0002-2572-1010
Anders M DaleDepartment of Radiology, University of California, San Diego, San Diego, California, USA.ORCID https://orcid.org/0000-0002-6126-2966
Carrie R McDonaldDepartment of Radiology, University of California, San Diego, San Diego, California, USA.
Thomas BeaumontDepartment of Radiology, University of California, San Diego, San Diego, California, USA.ORCID https://orcid.org/0000-0002-1940-1096
Tyler M SeibertDepartment of Radiology, University of California, San Diego, San Diego, California, USA.ORCID https://orcid.org/0000-0002-4089-7399
Jona Hattangadi-GluthDepartment of Radiation Medicine and Applied Sciences, University of California, San Diego, San Diego, California, USA.ORCID https://orcid.org/0000-0001-8222-606X
Santosh KesariPacific Neuroscience Institute, Santa Monica, California, USA.
Nikdokht FaridDepartment of Radiology, University of California, San Diego, San Diego, California, USA.ORCID https://orcid.org/0000-0002-0876-1934
Jeffrey D RudieDepartment of Radiology, University of California, San Diego, San Diego, California, USA.ORCID https://orcid.org/0000-0001-8609-8421

Funding

Mechanisms of Radiation-Induced Neurocognitive Decline (MIND): Longitudinal Study of Imaging Biomarkers and Risk and Resilience Factors Underlying Cognitive Phenotypes in Patients with GliomaR01CA289833 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jona A Hattangadi-Gluth, CARRIE R MCDONALD · 2025 to 2026
$1.3M
NCI NIH HHS R01 CA289833
6 · The paper itself

Abstract

Background: Evaluating longitudinal changes in gliomas is a time-intensive process with significant interrater variability. Automated segmentation could reduce interrater variability and increase workflow efficiency for assessment of treatment response. We sought to evaluate whether neural networks would be comparable to expert assessment of pre- and posttreatment diffuse gliomas tissue subregions including resection cavities. Methods: A retrospective cohort of 647 MRIs of patients with diffuse gliomas (average 55.1 years; 29%/36%/34% female/male/unknown; 396 pretreatment and 251 posttreatment, median 237 days post-surgery) from 7 publicly available repositories in The Cancer Imaging Archive were split into training (536) and test/generalization (111) samples. T1, T1-post-contrast, T2, and FLAIR images were used as inputs into a 3D nnU-Net to predict 3 tumor subregions and resection cavities. We evaluated the performance of networks trained on pretreatment training cases (Pre-Rx network), posttreatment training cases (Post-Rx network), and both pre- and posttreatment cases (Combined networks). Results: Segmentation performance was as good as or better than interrater reliability with median dice scores for main tumor subregions ranging from 0.82 to 0.94 and strong correlations between manually segmented and predicted total lesion volumes (0.94 < Conclusions: Neural networks that accurately segment pre- and posttreatment diffuse gliomas have the potential to improve response assessment in clinical trials and reduce provider burden and errors in measurement.

Indexed as

artificial intelligencebrain tumorsneural networksneuro-oncologysegmentation

Identifiers

PMID39290874
PMCPMC11407510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.